Global Alinia (nitazoxanide) Market Growth 2023-2029
Product Code:464020
Published Date: Feb 08,2023
Pages: 71
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
LPI (LP Information)' newest research report, the “Alinia (nitazoxanide) Industry Forecast” looks at past sales and reviews total world Alinia (nitazoxanide) sales in 2022, providing a comprehensive analysis by region and market sector of projected Alinia (nitazoxanide) sales for 2023 through 2029. With Alinia (nitazoxanide) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alinia (nitazoxanide) industry.
This Insight Report provides a comprehensive analysis of the global Alinia (nitazoxanide) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alinia (nitazoxanide) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Alinia (nitazoxanide) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alinia (nitazoxanide) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alinia (nitazoxanide).
The global Alinia (nitazoxanide) market size is projected to grow from US$ 175.6 million in 2022 to US$ 222.3 million in 2029; it is expected to grow at a CAGR of 222.3 from 2023 to 2029.
The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.
This report presents a comprehensive overview, market shares, and growth opportunities of Alinia (nitazoxanide) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Oral Suspension
Segmentation by application
Retail Pharmacy
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Romark Laboratories
Chugai Pharmaceutical
Lupin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Alinia (nitazoxanide) market?
What factors are driving Alinia (nitazoxanide) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alinia (nitazoxanide) market opportunities vary by end market size?
How does Alinia (nitazoxanide) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?